1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal ...

Roth began by sharing what he believes to be the single-most important characteristic of pharma company long-term survival ...

In today’s Pharma Pulse, the biopharma landscape enters a transformative phase as the US signs landmark PBM reforms into law, ...

The combination of GENEROUS for Medicaid, Globe for Medicare Part B and Guard for Medicare Part D will heavily impact the US drug market. President Trump’s rhetoric has been that other countries ...

In today’s Pharma Pulse, AstraZeneca faces a complete response letter for its self-injectable lupus drug, while the EMA gives ...

By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to ...

ORBIS Corporation's acquisition of Robinson Industries enhances manufacturing capabilities and accelerates production ...

Körber, a provider of manufacturing and supply chain solutions—including for the pharma industry—has struck a deal to acquire ...

In the final part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, outlines how real-time AI signal sharing across supply chain partners can help pharma ...

Hudicka also comments on practical steps can supply chain leaders take to build trust in AI-driven ecosystems without ...

For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...

Pharmaceutical Commerce | Journals | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.